Understanding Anxiety and Depression in COPD Patients
Author Information
Author(s): Milo A Puhan, Martin Frey, Stefan Büchi, Holger J Schünemann
Primary Institution: University Hospital of Zurich, Switzerland
Hypothesis
What is the minimal important difference of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease (COPD)?
Conclusion
The minimal important difference of the HADS is around 1.5 in COPD patients, indicating a significant change in their anxiety and depression levels.
Supporting Evidence
- The minimal important difference was estimated using both anchor-based and distribution-based methods.
- Correlations of the HADS depression score with anchors were found to be less than 0.5.
- The study included patients with a mean FEV1 of 34.3% predicted.
Takeaway
This study found that a change of about 1.5 points on a depression and anxiety test is important for COPD patients, meaning it can help doctors understand if treatments are working.
Methodology
The study used both anchor-based and distribution-based methods to determine the minimal important difference of the HADS in COPD patients.
Potential Biases
Correlations between HADS depression scores and anchors were low, which may indicate potential bias in the estimates.
Limitations
The study's sample size was relatively small, which may affect the generalizability of the findings.
Participant Demographics
Mean age of participants was 68.7 years, with 67% being male and having moderate to very severe COPD.
Statistical Information
Confidence Interval
95% CI 1.18–1.63
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website